Harvest Health And Recreation Inc. Acquires CBx Enterprises

Partnership to Bring Award-Winning Products from Evolab and CBx Sciences to Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) Stores across Eight States and One of Largest Footprints in the World.

DENVER & PHOENIX–(BUSINESS WIRE)–Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF), a vertically integrated cannabis company with one of the largest footprints in the United States, announced the acquisition of CBx Enterprises (“CBx”), whose technology is utilized by EvolabCBx Sciences and CBx Essentials.

Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) (“Harvest”) now holds exclusive national rights to CBx’s intellectual property, including all technology, methodologies, trademarks and formulations.

“CBx has established itself as the dominant leader in cannabis product development, research and innovation, and our partnership is a game-changer for expansion,” saidHarvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) Chairman Jason Vedadi. “Working with the CBx team will allow us to radically slash the lengthy and costly product development cycles in each new market that we enter and can now immediately offer some of the most trusted products in the cannabis industry. Bringing CBx’s team and products to Harvest Health & Recreation Inc.’s (CSE:HARV) (OTCQX:HTHHF) robust and aggressive portfolio of retail operations combines two of the most effective names in cannabis.”

CBx’s CO2 extraction, distillation, purification and manufacturing solutions – which brands such as Evolab utilize – are unrivaled in the cannabis industry and will be the cornerstone of all Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) production facilities. The company has an in-house analytical and product development laboratory headed by Noel Palmer, Ph.D., which has helped create top industry-first products, including the first CBG and Delta-8-THC offerings in Colorado.

Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) has created a vast infrastructure already reaching nearly every major medical and adult-use cannabis market in the U.S.,” said Nicole Smith, CEO, CBx Enterprises. “This arrangement will allow us to ensure that patients and consumers across the country have access to premium, consistent products based on our years of experience and award-winning technologies.”

CBx’s technology is used in Evolab’s product lines including Chroma™, Alchemy™, Colors and FreshTerps™, which established reputations as some of the most innovative cannabis products in the legal market and have been recognized in many cannabis industry award programs such as the Cannabis Business Awards, High Times Cannabis Cup, Hemp Connoisseur Championship and others.

CBx Sciences has introduced a unique line of therapeutic cannabis topicals, vapes and Gems featuring rare cannabinoids such as CBG and CBN paired with complementary botanical ingredients. CBx also recently announced a hemp-derived product line, CBx Essentials, available for distribution nationwide.

CBx Sciences and Evolab products will be available at Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HTHHF) locations beginning later this year and are currently available at hundreds of medical and adult-use locations across Colorado.

Please See Disclaimer


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Harvest Health & Recreation Inc. Market Jar Media Inc. has or expects to receive the following amounts from Native Ads Inc. in the USD amount of one hundred and sixty thousand, eight hundred and seventy five dollars for 42 campaign days (31 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.